International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
26(1), P. 27 - 27
Published: Dec. 24, 2024
The
inflammatory
response
consists
of
two
stages:
priming
and
triggering.
triggering
stage
is
marked
by
the
activation
inflammasomes,
which
are
cytosolic
protein
complexes
acting
as
platforms
for
inflammation.
Inflammasomes
divided
into
canonical
noncanonical
categories.
Inflammatory
lung
diseases
such
asthma,
chronic
obstructive
pulmonary
disease
(COPD),
acute
respiratory
distress
syndrome
(ARDS),
injury,
fibrosis
arise
from
inflammation
damage.
While
role
inflammasomes
in
these
well
demonstrated,
recent
findings
emphasize
critical
roles
regulating
various
conditions.
Particularly,
new
studies
highlight
their
involvement
diseases.
This
review
delves
research
on
regulatory
human
caspase-4
murine
caspase-11,
development
diseases,
potential
targeting
treatments.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(5)
Published: Oct. 1, 2023
Inflammasomes
are
a
group
of
protein
complex
located
in
cytoplasm
and
assemble
response
to
wide
variety
pathogen-associated
molecule
patterns,
damage-associated
cellular
stress.
Generally,
the
activation
inflammasomes
will
lead
maturation
proinflammatory
cytokines
pyroptotic
cell
death,
both
associated
with
inflammatory
cascade
amplification.
A
sensor
protein,
an
adaptor,
procaspase
interact
through
their
functional
domains
compose
one
subunit
inflammasome
complex.
Under
physiological
conditions,
functions
against
pathogen
infection
endogenous
dangers
including
mtROS,
mtDNA,
so
on,
while
dysregulation
its
can
unwanted
results.
In
recent
years,
advances
have
been
made
clarify
mechanisms
activation,
structural
details
them
(negative/positive)
multiple
disease
models
animal
human.
The
range
stimuli
makes
function
diverse
Here,
we
review
structure,
biological
functions,
therapeutic
targets
inflammasomes,
highlight
NLRP3,
NLRC4,
AIM2
which
most
well
studied.
conclusion,
this
focuses
on
process,
structure
well-studied
summarizing
predicting
approaches
for
treatment
prevention
as
target.
We
aim
provide
fresh
insight
into
new
solutions
challenges
field.
Journal of Ginseng Research,
Journal Year:
2022,
Volume and Issue:
46(6), P. 722 - 730
Published: April 5, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
the
pathogenic
virus
that
causes
disease
2019
(COVID-19),
with
major
symptoms
including
hyper-inflammation
and
cytokine
storm,
which
consequently
impairs
system
multiple
organs,
or
even
cause
death.
SARS-CoV-2
activates
inflammasomes
inflammasome-mediated
inflammatory
signaling
pathways,
are
key
determinants
of
hyperinflammation
storm
in
COVID-19
patients.
Additionally,
inhibits
inflammasome
activation
to
evade
host's
antiviral
immunity.
Therefore,
regulating
initiation
has
received
increasing
attention
as
a
preventive
measure
Ginseng
its
active
constituents,
ginsenosides
saponins,
improve
immune
exert
anti-inflammatory
effects
by
targeting
stimulation.
this
review
discussed
potential
therapeutic
roles
ginseng
based
on
regulatory
role
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(2), P. 1077 - 1077
Published: Jan. 5, 2023
We
previously
reported
that
Korean
red
ginseng
(KRG)
exerts
an
anti-inflammatory
role
through
inhibiting
caspase-11
non-canonical
inflammasome
in
macrophages;
however,
the
components
responsible
for
remained
unclear.
This
study
explored
activity
of
KRG
saponin
fraction
(KRGSF)
inflammasome-activated
macrophages.
KRGSF
inhibited
pyroptosis,
pro-inflammatory
cytokine
secretion,
and
inflammatory
mediator
production
J774A.1
cells.
A
mechanism
revealed
KRGSF-induced
action
was
mediated
via
suppressing
proteolytic
activation
gasdermin
D
(GSDMD)
Moreover,
increased
survival
lethal
septic
mice.
Taken
together,
these
results
reveal
KRGSF-mediated
with
a
novel
mechanism,
by
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(4), P. 2091 - 2091
Published: Feb. 8, 2024
Inflammasomes
are
intracellular
multiprotein
complexes
that
activate
inflammatory
signaling
pathways.
comprise
two
major
classes:
canonical
inflammasomes,
which
were
discovered
first
and
activated
in
response
to
a
variety
of
pathogen-associated
molecular
patterns
(PAMPs)
danger-associated
(DAMPs),
non-canonical
recently
only
lipopolysaccharide
(LPS).
Although
larger
number
studies
have
successfully
demonstrated
particularly
the
NLRP3
inflammasome,
play
roles
various
rheumatic
diseases,
including
rheumatoid
arthritis
(RA),
infectious
(IR),
gouty
(GA),
osteoarthritis
(OA),
systemic
lupus
erythematosus
(SLE),
psoriatic
(PA),
ankylosing
spondylitis
(AS),
Sjögren’s
syndrome
(SjS),
regulatory
such
as
mouse
caspase-11
human
caspase-4
these
diseases
still
largely
unknown.
Interestingly,
an
increasing
reported
possible
for
inflammasomes
pathogenesis
models
disease.
This
review
comprehensively
summarizes
discusses
recent
emerging
demonstrating
focusing
on
progression
types
provides
new
insights
into
strategies
developing
potential
therapeutics
prevent
treat
well
associated
by
targeting
inflammasomes.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(9), P. 4986 - 4986
Published: April 30, 2022
An
inflammatory
response
consists
of
two
consecutive
steps:
priming
and
triggering,
to
prepare
activate
responses,
respectively.
The
cardinal
feature
the
triggering
step
is
activation
intracellular
protein
complexes
called
inflammasomes,
which
provide
a
platform
for
signaling
pathways.
Despite
many
studies
demonstrating
regulatory
roles
canonical
inflammasomes
in
liver
diseases,
newly
discovered
non-canonical
diseases
are
still
largely
unknown.
Recent
have
reported
caspase-11
inflammasome
providing
strong
evidence
that
may
play
key
pathogenesis
diseases.
This
review
comprehensively
discusses
emerging
focusing
on
non-alcoholic
fatty
disease
(NAFLD),
steatohepatitis
(NASH),
injuries
its
underlying
mechanisms.
highlights
current
knowledge
new
insights
into
development
potential
therapeutics
prevent
treat
by
targeting
inflammasome.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(12), P. 10402 - 10402
Published: June 20, 2023
Inflammasomes
are
multiprotein
complexes
that
activate
inflammatory
responses
by
inducing
pyroptosis
and
secretion
of
pro-inflammatory
cytokines.
Along
with
many
previous
studies
on
diseases
induced
canonical
inflammasomes,
an
increasing
number
have
demonstrated
non-canonical
such
as
mouse
caspase-11
human
caspase-4
emerging
key
players
in
various
diseases.
Flavonoids
natural
bioactive
compounds
found
plants,
fruits,
vegetables,
teas
pharmacological
properties
a
wide
range
Many
successfully
flavonoids
play
anti-inflammatory
role
ameliorate
inhibiting
inflammasomes.
Others
the
roles
diseases,
new
mechanism
which
inhibit
This
review
discusses
recent
investigated
inflammasomes
further
provides
insight
into
developing
flavonoid-based
therapeutics
potential
nutraceuticals
against